TESTICULAR GAMETOGENIC AND STEROIDOGENIC ACTIVITIES IN CYCLOPHOSPHAMIDE TREATED RAT: A CORRELATIVE STUDY WITH TESTICULAR OXIDATIVE STRESS
- 1 January 2002
- journal article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 25 (3) , 281-292
- https://doi.org/10.1081/dct-120005891
Abstract
The present work examined the changes in testicular activities in relation to testicular oxidative stress in cyclophosphamide as well as human chorionic gonadotrophin (hCG) co-treated cyclophosphamide treated Wistar strain rats. Testicular activities were evaluated by the quantification of spermatogenesis and by the measurement of steroidogenic key enzyme activities along with plasma levels of testosterone. Testicular oxidative stress in relation to cyclophosphamide treatment was monitored by the study of products of free radicals like conjugated dienes and malondialdehyde (MDA) as well as the activity of testicular antioxidant enzymes like peroxidase and catalase. Cyclophosphamide treatment at the dose of 5 mg/kg body weight/day for 28 days resulted a significant diminution in the activities of testicular delta 5, 3 beta-hydroxysteroid dehydrogenase (delta 5, 3 beta-HSD), 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) activities, plasma level of testosterone along with significant reduction in the number of germ cells at stage-VII of spermatogenesis. Levels of testicular MDA and conjugated dienes both were elevated whereas testicular peroxidase and catalase activities both were inhibited significantly in cyclophosphamide treated rats in comparison to control. After hCG co-administration at the dose of 5 I.U./kg body weight/day for 28 days in cyclophosphamide treated rats resulted a significant protection in the activities of testicular peroxidase and catalase along with significant decrease in the levels of MDA and conjugated dienes to the control level. Moreover, the testicular steroidogenic key enzyme activities and spermatogenesis along with plasma levels of testosterone were restored to the control level. Therefore, it may be concluded that there is a correlation between testicular steroidogenic activities as well as spermatogenesis and testicular oxidative stress in cyclophosphamide treated rats. Moreover, as restoration of plasma testosterone to the control level is noted in hCG co-treated cyclophosphamide treated rat, therefore, the results suggest that testosterone may be the key regulator for this correlation.Keywords
This publication has 30 references indexed in Scilit:
- Effect of human chorionic gonadotrophin coadministration on ovarian steroidogenic and folliculogenic activities in cyclophosphamide treated albino ratsReproductive Toxicology, 2001
- Effect of ascorbic acid supplementation on liver and kidney toxicity incyclophoshamide-treated female albino rats.The Journal of Toxicological Sciences, 1999
- GONADAL DAMAGE FROM CHEMOTHERAPY AND RADIOTHERAPYEndocrinology and Metabolism Clinics of North America, 1998
- Impaired Detoxification of Reactive Oxygen and Consequent Oxidative Stress in Experimentally Cryptorchid Rat Testis1Biology of Reproduction, 1992
- Cyclophosphamide-induced disturbance of gonadotropin secretion manifesting testicular damageActa Endocrinologica, 1992
- Steroid Synthesis-Dependent, Oxygen-Mediated Damage of Mitochondrial and Microsomal Cytochrome P-450 Enzymes in Rat Leydig Cell Cultures*Endocrinology, 1987
- Chronic Low Dose Cyclophosphamide Treatment of Adult Male Rats: Effect on Fertility, Pregnancy Outcome and Progeny1Biology of Reproduction, 1986
- Suppression of Spermatogenesis in Patients with Behçet’s Disease Treated with Cyclophosphamide and ColchicineFertility and Sterility, 1981
- Gonadotropin responses to luteinizing releasing factor in boys treated with cyclophosphamide for nephrotic syndromeThe Journal of Pediatrics, 1976
- Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndromeThe Journal of Pediatrics, 1976